NCT00804414View on ClinicalTrials.gov

Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers

PHASE3CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions
DiabetesDiabetic Ulcer
Interventions
DRUG

SBG

Solution for topical use

DRUG

Placebo Comparator

Solutin for topical use

Trial Locations (1)

28040

Universidad Complutense de Madrid, Madrid

Sponsors
All Listed Sponsors
lead

Biotec Pharmacon ASA

INDUSTRY

NCT00804414 - Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter